Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,919 | -10,599 | -3,638 | -3,049 | -14,847 |
| Depreciation Amortization | 5 | 4 | 3 | 2 | 16 |
| Accounts payable and accrued liabilities | -106 | 30 | 960 | -465 | 218 |
| Other Working Capital | 76 | -8 | -77 | -1,109 | 1,568 |
| Other Operating Activity | 4,457 | 2,587 | -105 | 818 | -103 |
| Operating Cash Flow | $-12,486 | $-7,985 | $-2,856 | $-3,802 | $-13,149 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 48,889 | 48,889 | 48,766 | N/A | 29,827 |
| Financing Cash Flow | $48,889 | $48,889 | $48,766 | $N/A | $29,827 |
| Beginning Cash Position | 28,840 | 28,840 | 28,840 | 28,840 | 12,162 |
| End Cash Position | 65,243 | 69,744 | 74,749 | 25,037 | 28,840 |
| Net Cash Flow | $36,403 | $40,904 | $45,910 | $-3,802 | $16,678 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,486 | -7,985 | -2,856 | -3,802 | -13,149 |
| Free Cash Flow | -12,486 | -7,985 | -2,856 | -3,802 | -13,149 |